Raptor Pharmaceutical Inc. to Host Conference Call and Webcast to Discuss Phase 3 Clinical Trial Results on Tuesday, July 26, 2011 at Noon EDT

NOVATO, Calif., July 25, 2011 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (“Raptor” or the “Company”) (Nasdaq:RPTP), announced today that they will host a conference call and webcast noon Eastern Time on July 26, 2011, to comment on the Company’s positive Phase 3 RP103 clinical trial results.